(Q33410174)
Statements
1 reference
Efficacy and safety results from OCTAVIA, a single-arm phase II study evaluating front-line bevacizumab, carboplatin and weekly paclitaxel for ovarian cancer (English)
1 reference
Giovanni Scambia
1 reference
Antonio Gonzalez-Martin
1 reference
Bengt Tholander
1 reference
Daniel Stroyakovsky
1 reference
Martin Gore
1 reference
Nadezhda Kovalenko
1 reference
Ana Oaknin
1 reference
Julian Perez Ronco
1 reference
Ulrich Freudensprung
1 reference
OCTAVIA Investigators
1 reference
2 September 2013
1 reference
1 reference
49
1 reference
18
1 reference
3831-3838
1 reference
Identifiers
1 reference
1 reference